Developing a nanosensor platform to detect disease signatures in patient fluids
Nanosensor Array Platform to Capture Whole Disease Fingerprints
This study is working on a tiny sensor that can help doctors spot different diseases by looking at blood samples, using smart technology to make sure they can tell the difference between healthy and sick patients more accurately.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11092179 on NIH RePORTER |
What this research studies
This research focuses on creating a nanosensor array that can identify unique disease fingerprints from biofluids like blood serum. By analyzing the interactions of various molecules with these sensors, the project aims to enhance the accuracy of disease diagnosis and biomarker discovery. The approach utilizes machine learning to interpret complex data sets, allowing for better differentiation between healthy and diseased states. This innovative technology seeks to overcome the limitations of current biomarkers, which often lack specificity.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with conditions that currently lack specific biomarkers for diagnosis.
Not a fit: Patients with well-established biomarkers or those not undergoing diagnostic testing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and early diagnoses of diseases, improving patient outcomes.
How similar studies have performed: While the approach of using nanosensors for biomarker discovery is innovative, similar technologies have shown promise in preliminary studies, indicating potential for success.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Heller, Daniel Alan — Sloan-Kettering Inst Can Research
- Study coordinator: Heller, Daniel Alan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.